Cart
sales@molnova.com
BRS-3 agonist Compound A
CAS No. ——
BRS-3 agonist Compound A( —— )
Catalog No. M17034 CAS No. ——
A potent, selective, orally active bombesin receptor subtype-3 (BRS-3) agonist.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameBRS-3 agonist Compound A
-
NoteResearch use only, not for human use.
-
Brief DescriptionA potent, selective, orally active bombesin receptor subtype-3 (BRS-3) agonist.
-
DescriptionA potent, selective, orally active bombesin receptor subtype-3 (BRS-3) agonist with EC50 of 250/100 nM for human/rat BRS-3, resp+H1437+M1438.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayGPCR/G Protein
-
TargetBombesin Receptor
-
RecptorBombesin Receptor
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number——
-
Formula Weight428.532
-
Molecular FormulaC27H28N2O3
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES——
-
Chemical NameR-6-benzyl-N-tert-butyl-9-methoxy-7-oxo-6,7-dihydro-5H-dibenzo[c,e]azepine-5-carboxamide
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Nio Y, et al. Endocrinology. 2017 May 1;158(5):1298-1313.
molnova catalog
related products
-
CD80-IN-3
CD80-IN-3 is a potent CD80 inhibitor and inhibits CD80/CD28 interaction (Kd: 125 nM; EC50: 630 nM).
-
[D-Phe12,Leu14]-Bomb...
Bombesin receptor antagonist that inhibits bombesin binding to rat brain with an IC50 value of 2 μM. Inhibits amylase release in vitro (IC50 = 4 μM) and attenuates bombesin-mediated suppression of food intake in vivo.
-
BRS-3 agonist Compou...
A potent, selective, orally active bombesin receptor subtype-3 (BRS-3) agonist.
